AVE Science & Technology Co

AVE Science & Technology Co Working Capital

The Working Capital of AVE Science & Technology Co (688067.SS) as of Oct 24, 2026 is 216.62 M CNY. In the previous year, Working Capital was 235.26 M CNY — a change of -7.92% (lower).

Working Capital

216.62 MCNY

YoY

-7.92%

Last updated:

Working Capital of AVE Science & Technology Co is 2025 216.62 M CNY. Working Capital of AVE Science & Technology Co was 2024 235.26 M CNY. It decreases by -7.92% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AVE Science & Technology Co Stock analysis

What does AVE Science & Technology Co do? AVE Science & Technology Co., Ltd. generates revenue through the research, development, production, sale, and service of clinical testing and analysis instruments. Its main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables. These products are primarily sold to inspection departments within medical and health institutions in both domestic and overseas markets. The company serves healthcare facilities that require diagnostic equipment for laboratory testing and patient care. The firm's product portfolio targets healthcare institutions seeking advanced diagnostic tools for efficient clinical analysis. By focusing on specialized instruments like urine and stool analyzers, AVE Science & Technology addresses specific needs in medical testing departments. The company's domestic and international distribution channels ensure broad market access for its diagnostic solutions. AVE Science & Technology's revenue streams are derived from the sale of its comprehensive range of clinical testing instruments and related consumables. The company's domestic market presence and overseas sales contribute to its overall business performance. Its products support routine diagnostic procedures across various healthcare settings, driving consistent demand for its equipment and reagents. AVE Science & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AVE Science & Technology Co stock

Working Capital of AVE Science & Technology Co is 216.62 M CNY in 2025.

Working Capital of AVE Science & Technology Co changed from 235.26 M CNY to 216.62 M CNY, representing a -7.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Working Capital AVE Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.

Working capital is the difference between current assets and current liabilities. Positive working capital indicates a company can meet its short-term obligations.

Working Capital's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Working Capital's AVE Science & Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — AVE Science & Technology Co

All Key Metrics — AVE Science & Technology Co